viernes, 29 de septiembre de 2023

FDA approves bosutinib for pediatric patients with chronic myelogenous leukemia

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-bosutinib-pediatric-patients-chronic-myelogenous-leukemia?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario